Cellectar Biosciences Inc (CLRB) — Long-term Investment Intensity
Cellectar Biosciences Inc (CLRB) has a Long-term Investment Intensity of 0.2% as of June 2021. Long-term investments of $75.00K represent 0.2% of total assets of $47.74 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Cellectar Biosciences Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Cellectar Biosciences Inc Long-term Investment Intensity (2018–2020)
This chart shows how Cellectar Biosciences Inc's Long-term Investment Intensity has evolved across 3 annual periods from 2018 to 2020. As of June 2021, the intensity stands at 0.2%, reflecting long-term investments of $75.00K against total assets of $47.74 Million USD. Explore Cellectar Biosciences Inc (CLRB) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Cellectar Biosciences Inc (2018–2020)
The table below presents the year-by-year Long-term Investment Intensity for Cellectar Biosciences Inc from 2018 to 2020, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see market cap of Cellectar Biosciences Inc.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2020 | 0.1% | $75.00K | $58.66 Million | ▼ -0.5 pp |
| 2019 | 0.6% | $75.00K | $12.25 Million | ▼ -3.0 pp |
| 2018 | 3.6% | $540.82K | $15.05 Million | — |